Using mice subcutaneously inoculated with cancer cell lines, Vetizou and colleagues demonstrated that mice housed in specific pathogen-free conditions with fully intact microbiotas, had markedly improved tumor control relative to mice housed in germ free conditions, which lack a functional microbiota, following the administration of anti-CTLA4 immunotherapy (12). This evidence concerns the gene CTLA4 and neoplasm.